Commonwealth Equity Services’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
68,048
-3,400
-5% -$42.5K ﹤0.01% 2558
2026
Q1
$650K Buy
71,448
+5,891
+9% +$74.4K ﹤0.01% 2981
2025
Q4
$897K Buy
65,557
+1,109
+2% +$20.6K ﹤0.01% 2668
2025
Q3
$1.4M Sell
64,448
-9,229
-13% -$109K ﹤0.01% 2311
2025
Q2
$880K Buy
73,677
+3,700
+5% +$46.6K ﹤0.01% 2681
2025
Q1
$832K Buy
69,977
+2,918
+4% +$45.4K ﹤0.01% 2612
2024
Q4
$1.03M Sell
67,059
-583
-0.9% -$7.55K ﹤0.01% 2358
2024
Q3
$758K Buy
67,642
+2,400
+4% +$23K ﹤0.01% 2557
2024
Q2
$352K Buy
65,242
+1,158
+2% +$6.7K ﹤0.01% 3159
2024
Q1
$436K Buy
64,084
+4,852
+8% +$33.9K ﹤0.01% 2942
2023
Q4
$402K Sell
59,232
-9,298
-14% -$52.6K ﹤0.01% 2917
2023
Q3
$343K Hold
68,530
﹤0.01% 2907
2023
Q2
$496K Sell
68,530
-1,030
-1% -$8.76K ﹤0.01% 2633
2023
Q1
$587K Sell
69,560
-11,495
-14% -$101K ﹤0.01% 2410
2022
Q4
$686K Sell
81,055
-2,155
-3% -$20.4K ﹤0.01% 2216
2022
Q3
$862K Buy
83,210
+13,230
+19% +$174K ﹤0.01% 2005
2022
Q2
$913K Buy
69,980
+15,100
+28% +$154K ﹤0.01% 1962
2022
Q1
$571K Buy
54,880
+20,830
+61% +$190K ﹤0.01% 2416
2021
Q4
$382K Buy
34,050
+23,590
+226% +$353K ﹤0.01% 2755
2021
Q3
$185K Buy
+10,460
New +$196K ﹤0.01% 3301

Other funds holding CLPT

Commonwealth Equity Services's CLPT Position: Q2 2026 in Review

Commonwealth Equity Services reduced its ClearPoint Neuro (CLPT) stake by 4.8% in Q2 2026, selling an estimated $42.5K and leaving 68,048 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2558.

Commonwealth Equity Services first reported a position in CLPT in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.4M in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Commonwealth Equity Services held 68,048 shares of ClearPoint Neuro worth $1.21M as of Q2 2026.
  • Commonwealth Equity Services sold 3,400 ClearPoint Neuro shares in Q2 2026, an estimated $42.5K.
  • ClearPoint Neuro made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2558 holding.
  • Commonwealth Equity Services first reported a position in ClearPoint Neuro in Q3 2021 and has held it in 20 quarters since.
  • Commonwealth Equity Services's ClearPoint Neuro position peaked at $1.4M in Q3 2025.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.